Amgen's Aimovig Riding High With Strong Prescriber, Payer Acceptance
Executive Summary
New commercial head Murdo Gordon described Aimovig as one of the best launches he's ever seen and said growth should continue – though moderate – based on prescriber experience and rapid transitions from free drug to reimbursed prescriptions.